EMEA-000788-PIP02-11-M09

Key facts

Invented name
Lixiana
Active substance
Edoxaban (tosylate)
Therapeutic area
  • Cardiovascular diseases
  • Haematology-Hemostaseology
Decision number
P/0013/2020
PIP number
EMEA-000788-PIP02-11-M09
Pharmaceutical form(s)
  • Film-coated tablet
  • Orodispersible tablet
  • Age-appropriate dosage form, other
Condition(s) / indication(s)
  • Prevention of arterial thromboembolism
  • Prevention of venous thromboembolism
  • Treatment of venous thromboembolism
Route(s) of administration
Oral use
Contact for public enquiries
Daiichi Sankyo Europe GmbH

Tel. +49 897808423
E-mail: alexandra.mees@daiichi-sankyo.eu

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating